Swiss National Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-43,200
| Closed | -$483K | – | 2562 |
|
|
2023
Q3 | $483K | Hold |
43,200
| – | – | ﹤0.01% | 2514 |
|
|
2023
Q2 | $924K | Buy |
43,200
+600
| +1% | +$12.8K | ﹤0.01% | 2335 |
|
|
2023
Q1 | $1.72M | Sell |
42,600
-4,900
| -10% | -$198K | ﹤0.01% | 1932 |
|
|
2022
Q4 | $2.21M | Buy |
47,500
+800
| +2% | +$37.2K | ﹤0.01% | 1831 |
|
|
2022
Q3 | $2.42M | Buy |
46,700
+700
| +2% | +$36.3K | ﹤0.01% | 1734 |
|
|
2022
Q2 | $2.17M | Buy |
46,000
+2,700
| +6% | +$128K | ﹤0.01% | 1851 |
|
|
2022
Q1 | $3.08M | Buy |
43,300
+3,300
| +8% | +$235K | ﹤0.01% | 1764 |
|
|
2021
Q4 | $2.99M | Hold |
40,000
| – | – | ﹤0.01% | 1790 |
|
|
2021
Q3 | $2.27M | Hold |
40,000
| – | – | ﹤0.01% | 1973 |
|
|
2021
Q2 | $1.76M | Buy |
40,000
+1,000
| +3% | +$44K | ﹤0.01% | 2193 |
|
|
2021
Q1 | $1.92M | Buy |
39,000
+500
| +1% | +$24.7K | ﹤0.01% | 2028 |
|
|
2020
Q4 | $1.62M | Hold |
38,500
| – | – | ﹤0.01% | 2028 |
|
|
2020
Q3 | $1.76M | Buy |
38,500
+700
| +2% | +$32.1K | ﹤0.01% | 1782 |
|
|
2020
Q2 | $1.9M | Buy |
37,800
+9,100
| +32% | +$457K | ﹤0.01% | 1745 |
|
|
2020
Q1 | $1.48M | Buy |
28,700
+400
| +1% | +$20.6K | ﹤0.01% | 1632 |
|
|
2019
Q4 | $1.75M | Buy |
28,300
+600
| +2% | +$37.1K | ﹤0.01% | 1810 |
|
|
2019
Q3 | $1.66M | Buy |
27,700
+600
| +2% | +$36K | ﹤0.01% | 1766 |
|
|
2019
Q2 | $2.29M | Buy |
27,100
+600
| +2% | +$50.6K | ﹤0.01% | 1612 |
|
|
2019
Q1 | $2.53M | Buy |
26,500
+800
| +3% | +$76.4K | ﹤0.01% | 1509 |
|
|
2018
Q4 | $1.82M | Buy |
25,700
+700
| +3% | +$49.6K | ﹤0.01% | 1639 |
|
|
2018
Q3 | $2.14M | Hold |
25,000
| – | – | ﹤0.01% | 1678 |
|
|
2018
Q2 | $2.9M | Hold |
25,000
| – | – | ﹤0.01% | 1463 |
|
|
2018
Q1 | $2.02M | Buy |
25,000
+1,500
| +6% | +$121K | ﹤0.01% | 1632 |
|
|
2017
Q4 | $1.38M | Hold |
23,500
| – | – | ﹤0.01% | 1891 |
|
|
2017
Q3 | $1.1M | Hold |
23,500
| – | – | ﹤0.01% | 2003 |
|
|
2017
Q2 | $846K | Hold |
23,500
| – | – | ﹤0.01% | 2153 |
|
|
2017
Q1 | $724K | Buy |
23,500
+1,200
| +5% | +$37K | ﹤0.01% | 2215 |
|
|
2016
Q4 | $747K | Hold |
22,300
| – | – | ﹤0.01% | 2208 |
|
|
2016
Q3 | $593K | Hold |
22,300
| – | – | ﹤0.01% | 2264 |
|
|
2016
Q2 | $492K | Buy |
22,300
+5,800
| +35% | +$128K | ﹤0.01% | 2360 |
|
|
2016
Q1 | $468K | Buy |
16,500
+3,100
| +23% | +$87.9K | ﹤0.01% | 2340 |
|
|
2015
Q4 | $442K | Hold |
13,400
| – | – | ﹤0.01% | 2327 |
|
|
2015
Q3 | $484K | Buy |
13,400
+1,700
| +15% | +$61.4K | ﹤0.01% | 2195 |
|
|
2015
Q2 | $526K | Buy |
11,700
+3,300
| +39% | +$148K | ﹤0.01% | 2213 |
|
|
2015
Q1 | $257K | Hold |
8,400
| – | – | ﹤0.01% | 2428 |
|
|
2014
Q4 | $427K | Hold |
8,400
| – | – | ﹤0.01% | 2265 |
|
|
2014
Q3 | $332K | Hold |
8,400
| – | – | ﹤0.01% | 2300 |
|
|
2014
Q2 | $362K | Buy |
8,400
+2,600
| +45% | +$112K | ﹤0.01% | 2317 |
|
|
2014
Q1 | $232K | Buy |
5,800
+1,500
| +35% | +$60K | ﹤0.01% | 2405 |
|
|
2013
Q4 | $117K | Buy |
+4,300
| New | +$117K | ﹤0.01% | 2464 |
|